Deepika R. Dokuru

Deepika R. Dokuru

Auto-generated profile, based on publicly available information

Deepika R. Dokuru

Indo US Organization for Rare Diseases (IndoUSrare), Herndon, VA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2017 in The Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
ALAmy Lin
Amy Lin
CCChristopher R.K. Ching
Christopher R.K. Ching
AVAriana Vajdi
Ariana Vajdi
DSDaqiang Sun
Daqiang Sun
RJRachel K. Jonas
Rachel K. Jonas
CBCarrie E. Bearden
Carrie E. Bearden
Reciprocal chromosomal rearrangements at the 22q11.2 locus are associated with elevated risk of neurodevelopmental disorders. The 22q11.2 deletion confers the highest known genetic risk for schizophrenia, but a duplication in the same region is strongly associated with autism and is less common in schizophrenia cases than in the general population. Here we conducted the first study of 22q11.2 gene dosage effects on brain structure in a sample of 143 human subjects: 66 with 22q11.2 deletions (22q-del; 32 males), 21 with 22q11.2 duplications (22q-dup; 14 males), and 56 age- and sex-matched controls (31 males). 22q11.2 gene dosage varied positively with intracranial volume, gray and white matter volume, and cortical surface area (deletion < control < duplication). In contrast, gene dosage varied negatively with mean cortical thickness (deletion > control > duplication). Widespread differences were observed for cortical surface area with more localized effects on cortical thickness. These diametric patterns extended into subcortical regions: 22q-dup carriers had a significantly larger right hippocampus, on average, but lower right caudate and corpus callosum volume, relative to 22q-del carriers. Novel subcortical shape analysis revealed greater radial distance (thickness) of the right amygdala and left thalamus, and localized increases and decreases in subregions of the caudate, putamen, and hippocampus in 22q-dup relative to 22q-del carriers. This study provides the first evidence that 22q11.2 is a genomic region associated with gene-dose-dependent brain phenotypes. Pervasive effects on cortical surface area imply that this copy number variant affects brain structure early in the course of development. SIGNIFICANCE STATEMENT Probing naturally occurring reciprocal copy number variation in the genome may help us understand mechanisms underlying deviations from typical brain and cognitive development. The 22q11.2 genomic region is particularly susceptible to chromosomal rearrangements and contains many genes crucial for neuronal development and migration. Not surprisingly, reciprocal genomic imbalances at this locus confer some of the highest known genetic risks for developmental neuropsychiatric disorders. Here we provide the first evidence that brain morphology differs meaningfully as a function of reciprocal genomic variation at the 22q11.2 locus. Cortical thickness and surface area were affected in opposite directions with more widespread effects of gene dosage on cortical surface area.

2 November 2023 in Behavior Genetics
Verified
Journal Article
Closed access
PDF file
DDDeepika R. Dokuru
Deepika R. Dokuru
THTanya B. Horwitz
Tanya B. Horwitz
SFSamantha M. Freis
Samantha M. Freis
MSMichael C. Stallings
Michael C. Stallings
MEMarissa A. Ehringer
Marissa A. Ehringer

2 January 2025 in Developmental Neuropsychology
Verified
Journal Article
Closed access
FTFrancesca E. Trane
Francesca E. Trane
KPKatie N. Paulich
Katie N. Paulich
DDDeepika R. Dokuru
Deepika R. Dokuru
EWErik G. Willcutt
Erik G. Willcutt
Children with Attention-Deficit/Hyperactivity Disorder (ADHD) often struggle with writing composition, possibly due to deficits in executive functions and processing speed. This study examined 518 children with ADHD and 851 controls to assess these effects. Multiple mediation tested whether executive functions (i.e., working memory, inhibition) and processing speed partially mediated the association between inattention and writing composition, controlling for transcription. Results showed inattention negatively predicted writing composition. Executive function accounted for nearly 10%, and processing speed nearly 17%, of the variance in this association. Findings highlight the contributions of executive functions and processing speed to writing difficulties in ADHD.

1 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
LMLavanyaa Manjunatha
Lavanyaa Manjunatha
MSM Saundarya
M Saundarya
DDDeepika Dokuru
Deepika Dokuru
NVNisha Venugopal
Nisha Venugopal
JWJenifer Ngo Waldrop
Jenifer Ngo Waldrop
HRHarsha K Rajasimha
Harsha K Rajasimha
Background: Addressing inequities and health disparities for medically underserved populations (MUPs) is critical, as they already face systemic bias and barriers, such as historical mistrust of healthcare systems. To achieve health equity, we need systematic approaches to measuring, quantifying, and reporting diversity, equity, inclusion, and accessibility (DEIA) metrics. Methods: The objective of the study was to analyze literature and clinical trials to summarize the current state of demographics and socioeconomic factors (SF) reporting for MUPs in US-based RD clinical research. PubMed, Cochrane Library, and ClinicalTrials.gov were searched (1983– 2023). A universal set of 30,303 unique RD terms from the Genetic and Rare Diseases Information Center, Orphanet, Rare-X, and ClinicalTrials.gov was used to filter publications and clinical trials. Publications that reported demographics or SFs, were US-based, and involved one or more RDs were included for analysis. Clinical trials that were US-based, involved an RD, and had study results posted were also included. Age, sex or gender, race, ethnicity, and SF data were extracted and analyzed using descriptive statistics. Race and ethnicity data were compared with the US census. The representation of MUPs in RD clinical research was assessed based on the frequency of publications and clinical trials reporting 13 variables. Results: We reviewed 234 publications and 8475 RD clinical trials. Age was the most reported demographic variable (publications: 94%; clinical trials: 100%), followed by sex or gender (86.3%; 100%). Race (50%; 45.7%) and ethnicity (29.9%; 38.5%) were less frequently reported and often in a variable format in publications compared with the ClinicalTrials.gov database. At least one SF was reported in 15.8% of the publications and 0.2% of the trials. American Indian or Native Alaskan, Asian, Hispanic, and Latino participants were significantly underrepresented compared with the US census averages. Data were largely absent for other MUPs: lesbian, gay, bisexual, transgender, and queer or questioning individuals, rural residents, veterans, immigrants, and those affected by disability and poverty. Conclusions: Significant gaps exist in demographics and SF reporting in RD clinical research, and several MUPs are underrepresented. Therefore, a framework to enhance DEIA in RD research is urgently needed.